Amedisys (AMED) Misses Q3 EPS by 17c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Net income attributable to noncontrolling interests: -66K
Today's EPS Names:
CCEL, SLP, TMQ, More
Financial Fact:
Net income attributable to noncontrolling interests: -66K
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q3 EPS of $1.00, $0.17 worse than the analyst estimate of $1.17. Revenue for the quarter came in at $587.67 million versus the consensus estimate of $589.39 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta Platforms (META) Added to BofA US 1 List
- Hims and Hers (HIMS) PT Raised to $37 at BofA Securities
- Wolfe Research Upgrades Grainger (GWW) to Peerperform (correction)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
